戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ce vaccine immunity against lethal pulmonary blastomycosis.
2 l development against experimental pulmonary blastomycosis.
3 port a potential role for antigen testing in blastomycosis.
4  retained pathogenicity in a murine model of blastomycosis.
5  role of the WI-1 adhesin in pathogenesis of blastomycosis.
6 y transfer protection in murine experimental blastomycosis.
7 mals from death due to progressive pulmonary blastomycosis.
8 s with histoplasmosis and, to lesser extent, blastomycosis.
9  with coccidioidomycosis, histoplasmosis, or blastomycosis.
10 ycosis and 50 cases/100 000 person-years for blastomycosis.
11  for coccidioidomycosis, and 78% (40/51) for blastomycosis.
12 cute respiratory distress syndrome caused by blastomycosis.
13 d outcomes of patients with severe pulmonary blastomycosis.
14 stern countries, and 7 reports of veterinary blastomycosis.
15  and also identified 7 reports of veterinary blastomycosis.
16  less common with histoplasmosis (14.0%) and blastomycosis (13.1%) versus influenza (20.2%).
17  less common with histoplasmosis (14.0%) and blastomycosis (13.1%) vs. influenza (20.2%).
18                     Fever was less common in blastomycosis (2.6%), histoplasmosis (5.3%) and coccidio
19                     Fever was less common in blastomycosis (2.6%), histoplasmosis (5.3%), and coccidi
20 ), 18 of 31 Chagas disease (58%), 7 of 28 SA blastomycosis (25%), and 14 of 83 leprosy sera (17%).
21    In Blastomyces dermatitidis, the agent of blastomycosis, a respiratory and disseminated mycosis of
22 Outdoor activities were not risk factors for blastomycosis among cluster case patients or when compar
23 eated with steroids, leading to disseminated blastomycosis and acute respiratory distress syndrome (A
24  232 patients, among whom four had confirmed blastomycosis and both the Gotham and MiraVista EIAs wer
25                       We identified incident blastomycosis and histoplasmosis cases from 2013 to 2023
26 9 times (95% CI: 1.6-2.2) rates in 2013, for blastomycosis and histoplasmosis, respectively.
27 lysis revealed increasing incidence rates of blastomycosis and histoplasmosis, with increasing diagno
28 phic characterization of the fungal diseases blastomycosis and histoplasmosis.
29  not appear to improve the outcome of murine blastomycosis and may enhance the infection.
30 amples from a patient with culture-confirmed blastomycosis and one from a patient with histoplasmosis
31 r ability to investigate the pathogenesis of blastomycosis and other similar fungal diseases.
32 tients with histoplasmosis, 15 patients with blastomycosis, and 14 healthy subjects.
33 s, malaria, schistosomiasis, histoplasmosis, blastomycosis, and coccidioidomycosis.
34 osis, Blastomyces dermatitidis, the agent of blastomycosis, and Histoplasma capsulatum, the agent of
35                     As the susceptibility to blastomycosis appeared to be related to an early event a
36 with histoplasmosis, coccidioidomycosis, and blastomycosis are diagnosed in significant numbers outsi
37      Coccidioidomycosis, histoplasmosis, and blastomycosis are underrecognized and frequently misdiag
38 mpared the clinical features and outcomes of blastomycosis between immunocompromised and immunocompet
39  present them could modulate immunity during blastomycosis by selection and display of WI-1 peptides.
40 cultures and primary clinical specimens from blastomycosis cases from New York patients.
41                                    Cutaneous blastomycosis (CB) is associated with a variety of skin
42                                              Blastomycosis, coccidioidomycosis, and histoplasmosis ca
43 10-CM), diagnosis codes during 2016-2017 for blastomycosis, coccidioidomycosis, histoplasmosis, pneum
44 -10-CM) diagnosis codes during 2016-2017 for blastomycosis; coccidioidomycosis; histoplasmosis; pneum
45 vaccine immunity against lethal experimental blastomycosis, compared with wild-type control mice.
46                   We reevaluated 20 cases of blastomycosis diagnosed in South Africa between 1967 and
47 asmosis, 37 726 coccidioidomycosis, and 6109 blastomycosis diagnoses in unique persons from 2007-2016
48 had >=1 healthcare visits before receiving a blastomycosis diagnostic test (P = .02) and to have been
49 r understand the ecology and epidemiology of blastomycosis due to B. dermatitidis and B. gilchristii.
50                                              Blastomycosis due to Blastomyces dermatitidis and Blasto
51 e of histoplasmosis, coccidioidomycosis, and blastomycosis for each US county.
52 spective study of adult patients with proven blastomycosis from 2004-2016 was conducted at the Univer
53 ewed published cases of human and veterinary blastomycosis from Africa and the Middle East.
54                                              Blastomycosis has been reported from countries in Africa
55                                              Blastomycosis has been reported from countries in Africa
56 tomyces dermatitidis, the etiologic agent of blastomycosis, has 2 genetic groups and shows varied cli
57       We estimated high incidence in states (blastomycosis: Illinois, Kentucky, and West Virginia; hi
58 ases; these findings expand understanding of blastomycosis in New York.
59 pid diagnostics may improve the diagnosis of blastomycosis in resource-limited countries.
60 nt recipient with donor-derived disseminated blastomycosis in the early posttransplant period.
61                                              Blastomycosis incidence rates among Hispanic or Latino a
62 d historical case patients, and to calculate blastomycosis incidence rates.
63 There were 1848 patients with a diagnosis of blastomycosis included in the study.
64 We identified 172 unique human patients with blastomycosis, including 159 patients from 25 African co
65 We identified 172 unique human patients with blastomycosis, including 159 patients from 25 African co
66                                              Blastomycosis is a potentially life-threatening infectio
67                                              Blastomycosis is an environmentally acquired fungal infe
68 uated over a 10-year period in an area where blastomycosis is endemic.
69  dimorphic fungus and the causative agent of blastomycosis, is widely considered an extracellular pat
70                           Early suspicion of blastomycosis may prompt earlier diagnosis and treatment
71 he largest published cohort of patients with blastomycosis, mortality for patients on MV is high at ~
72                                              Blastomycosis occurs throughout Africa and the Middle Ea
73              This was the largest documented blastomycosis outbreak in the United States.
74                                   In 2023, a blastomycosis outbreak was detected among workers at a p
75 clonal antibody (MAb) or in immune sera from blastomycosis patients.
76 as detected with sera from histoplasmosis or blastomycosis patients.
77                      Laboratory diagnosis of blastomycosis relies on a combination of methods, includ
78   Outcomes of patients with severe pulmonary blastomycosis requiring mechanical ventilation (MV) are
79 ave a greater influence on dissemination for blastomycosis than immune defense.
80 ts had an 18-fold higher annual incidence of blastomycosis than the general population.
81 ent mice were more resistant to experimental blastomycosis than were intact littermates, and passive
82 hown in a mouse model of vaccination against blastomycosis that antifungal memory CD8(+) T cells are
83 nvestigated an increase in reported cases of blastomycosis that occurred during 2009-2010 in Marathon
84                             This outbreak of blastomycosis, the largest ever reported, was characteri
85                     The rate of disseminated blastomycosis was similar among NIC, SOT, and non-SOT IC
86   Over the 5 decades, South African cases of blastomycosis were caused by species that are distinct f
87 s of histoplasmosis, coccidioidomycosis, and blastomycosis were defined by International Classificati
88 from 37 patients with a confirmed history of blastomycosis were tested for a response to WI-1 in prim
89 us diseases (leprosy and South American (SA) blastomycosis), which are prevalent in the same geograph
90      Immature mice are highly susceptible to blastomycosis, which is similar to other mycoses and has
91 s as the predominant pathogen in 38 cases of blastomycosis, while B. gilchristii was a minor pathogen
92 nts with clinical and laboratory evidence of blastomycosis who had spent >=40 hours in Delta County s
93  Patients aged >18 years with a diagnosis of blastomycosis who received MV were included.
94                 Tests using a mouse model of blastomycosis with either yeast or spore inocula showed